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following parameters: TR/TE 14.0/5.22ms, ﬂip angle 308, 28 partitions,
partition thickness 0.5 mm, FOV 80 mm, matrix size 512512, voxel
size 0.150.15 mm, 32 averages. The total imaging time was 60 min.
Images were evaluated using a scanner software package (Syngo,
Siemens). The SC was outlined and the mean signal was calculated. A
second ROI was placed outside the animal contours for noise
measurement. The mean signal-to-noise ratio (SNR) and standard
deviation (SD) were calculated.
Results: After 2–3 days, a homogeneous enhancement in the SC lasting
for 36 h was observed, after which a slow washout started. Uninjured
animals displayed a homogeneous SNR of about 18without and 36with
contrast agent throughout the SC. Proximal to the injury, injured mice
showed an SNRcomparable to uninjuredmice. Onmoving further distal
towards the lesion, the SNR gradualy decreased, reaching background
levels just at the lesion site.
Conclusion: An in vivo method for structural and functional spinal
cord imaging in mice using MEMRI was developed. Manganese was
readily taken up and transported through the spinal cord althoughmeans
of uptake and transportation need to be elucidated. Changes in
manganese uptake proﬁles on comparing injured and healthy mice
suggest a function-dependent decrease in uptake in the injured mice.
The decrease in enhancement proximal to the lesion site may correlate
with dying back of axons. The decrease to baseline levelsmay indicate a
near total loss of functional neurons at these levels. Correlation with
histology supports this hypothesis.
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Rationale and Objectives: A ﬁrst clinical trial of orally administered
manganese with and without ascorbic acid as a promoting agent in liver
MRI was planned. The objectives of the study were to assess efﬁcacy of
the contrast agent in doses up to 100 mmol/kg bw, assess whether
addition of ascorbic acid (molar ratio 1:2) to the contrast agent improved
enhancements in the liver to such a degree that it may be of clinical
importance and to assess acute safety.
Methods: Eighteen healthy adult males were enrolled in the trial. The
mean age was 25.0 years and mean weight 77.6 kg. Contrast medium:
drug: MnCl2 doses were 25, 50 and 100 mmol/kg bw, respectively and
promoting agent: ascorbic acid doseswere 50, 100 and 200mmol/kg bw,
respectively. The trial was designed as a phase I, cross-over trial with
two study periods separated by a wash-out period of 4 weeks.
All imaging was performed on a 1.5 T clinical MRI system (Siemens
Somatom Vision, Erlangen, Germany). Three pulse sequences in the
abdomen were used: (i) T1-weighted axial gradient-echo (GE), TR/TE
52.5/4.8 ms, ﬂip angle 808, thickness 10.0 mm and scan time 20 s; (ii) as
for (i) but in the coronal plane; and (iii) T1-weighted axial spin-echo
(SE), TR/TE 250/12 ms, fat suppression, thickness 10.0 mm, averages 7
and scan time 5 min 39 s. To gather information about contrast passage
from ventricle to small intestine, occasionally more pulse sequences
were used in the coronal plane, but no quantitative analysis was
performed of the bowel distribution of the contrast agent. Phantom vials
containing standardized Ni–agarose gels were placed in a ﬁxed position
under the patient in the bed and used for signal intensity measurements.
Time points for imagingwere precontrast and 1, 2.5, 4, 6, 9 and 24 h after
MnCl2 intake. Safety parameters assessed in the trial were clinical
examinations and vital signs including heart rate and blood pressure.
Hematology and clinical chemistry were assessed with standard
laboratory procedures.
Results: All pulse sequences showed a clear dose–response in the liver.
High enhancements in the liver were seen between 2.5 and 6 h after
MnCl2 intake. At a manganese dose of 50 mmol/kg bw with ascorbic
acid and at a dose 100mmol/kg bw both without and with ascorbic acid,
the hepatic enhancements were higher than 100%, GE pulse sequence.
Using the volunteers as their own controls, the promoting effect of
ascorbic acid was signiﬁcant at a manganese dose of 100 mmol/kg bw.
The contrast agent distributed well in the small intestine, delineating
intra-abdominal organs well. No serious or unexpected adverse events
were encountered. The drug was generally tolerated well except for
gastrointestinal adverse events such as loose stool (n¼ 12), nausea (6)
and vomiting (1). No signiﬁcant alteration in hematology or clinical
chemistry was seen.
Conclusion: Oral manganese is easy to use and has few side-effects.
Besides the liver-speciﬁc effect, the agent delineates the intestine.
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Rationale andObjectives: Recently, a new liver speciﬁcMRagent has
been introduced that is administered orally and only small amounts enter
the general circulation. It is the only contrast medium that is delivered to
the liver in high doses in the portal vein and very low doses in the hepatic
artery. It is taken up by the hepatocytes and excreted together by the bile.
We recently received permission from the Danish Health Authorities to
use CMC-001 clinically (phase IV). In this paper we evaluate
retrospectively our preliminary experience.
Methods: Six patients were studied. All had known liver metastases
from colorectal cancers. Frommidnight the patients were not allowed to
drink or eat. Between 8 and 9 a.m. the patients drank CMC-001
dissolved in 400 mL of water and 2 h later the MR examination (1.5 T)
took place. The sequences are still being optimized.
Results: In three of the six patients, important new knowledge was
obtained. The uptake in the liverwas excellent in all patients. Therewere
segmental differences in the uptake in four of the six patients, probably
due to early ﬁbrosis induced by chemotherapeutics or decreased portal
vein ﬂow due to metastatic compression. There was excellent
visualization of the biliary system on the T1-weighed images. No
contrast medium adverse events were reported.
Conclusion: CMC-001 seems to be useful in the work-up of patients
with liver metastases regarding both the liver parenchyma and the
biliary tract. Further research is strongly warranted.
Financial disclosure: Thomsen HS. Manganese containing magnetic
resonance contrast agent. US Patent 6 015 545, 18 January 2000.
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Objective: Evaluation of the diagnostic performance of oral manga-
nese as a new contrastmedium in liverMR imaging in patients with liver
metastases.
Method and Materials: Fifteen patients with known liver metastases
were examined with MRI at 1.5 and 3 T before and 3 h after oral
administration of Mn contrast agent diluted in 400 mL of water. MRI
included T1-weighted FLASH breathold sequences in coronal and
transversal planes. At 1.5 T, contiguous 5 mm slices and at 3 T 3 mm
slices were made. Additionally, a T2-weighted true-FISP sequence was
performed to recognize liver cysts and hemangiomas. Contrast between
liver tissue and metastases was determined on the pre- and post-Mn
contrast scans. The homogeneity of liver enhancementwas evaluated. In
addition, the number of detected liver metastases and bowel and bile
duct opaciﬁcation was evaluated.
Results: There were no side-effects after the intake of oral Mn contrast
agent. The mean liver metastases contrast improved at 1.5 and 3 T by
factors of 2.1 and 1.5, respectively. Higher liver metastases contrast
increased the number of detected liver metastases by more than 50% at
both 1.5 and 3 T. In patients with a history of chemotherapy, liver
enhancementwas inhomogeneous, probably owing to disturbance of the
portal circulation; nonetheless, this did not inﬂuence the improved
metastases detection. In addition, bowel opaciﬁcation was improved in
all patients and excretion of contrast medium through the bile allowed
visualization of the hepatic duct, gallbladder and choledochal duct on
T1-weighted images in all patients.
Conclusions: This pilot study shows that oral Mn contrast medium is a
simple and promising contrast agent, which results in improved
visualization of liver metastases by a selective increase in the liver
signal and also bowel and bile duct opaciﬁcation is obtained using this
contrast agent.
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Rationale and Objective: Although the use of CO2 for intra-articular
conventional arthrography is feasible, it is hardly used because there are
noadvantagesover the useof air. InMRI, direct arthrography is performed
by using dilute Gd–DTPA. However, this intra-articular use lacks FDA
approval and gadolinium compounds are expensive in comparison with
CO2. We decided to evaluate its feasibility for direct MR arthrography.
Materials andMethods: For the animal experiment, a pigweighting 15
kgwas used.After baseline imagingandMRI-guided puncture of theknee
joints, 12 cm3 of CO2 was injected intra-articularly. A 1.5 T system
(MagnetomSonata,SiemensMedical Solutions,Erlangen,Germany)was
used. MR images were acquired using sagittal T1-weighted 3D spoiled
gradient-echo (TR/TE 40/10 ms slice thickness 2.5 mm) and T1-weighted
(TR/TE 500/12ms, slice thickness 4mm) and T2/proton density-weighted
(TR/TE 1740/11/80 ms, slice thickness 4 mm) spin-echo sequences.
Results: CO2 resulted in loss of signal and hardly caused susceptibility
artifacts. Owing to its bright appearance with most MR sequences,
articular cartilage was sharply delineated on the CO2 MR arthrograms.
Also, structures with low signal intensity such as cruciates and menisci
were well visualized. Only tiny susceptibility artifacts occurred.
Discussion: As is known, CO2 is a cheap agent suitable for direct intra-
articular injection and ready for clinical use. As inCO2MRangiography
(1), CO2 replaces the H-spins present, resulting in signal loss without
inducing signiﬁcant susceptibility artifacts.
Although this new kind of direct MR arthrography especially improves
the delineation of structures with high signals in various sequences such
as cartilage and bone, structures with relatively low signals such as
menisci and cruciates are also well visualized. This is also true during
the use of the driven equilibrium sequences used for visualization of
cartilage (2).
Owing to the high contrast, CO2 MR arthrography might visualize
smaller lesions and ruptures better than diagnostic methods applied so
far (3).
In conclusion. direct CO2MRarthrography is new, feasible and possibly
helpful in cartilage imaging.
References
1. Wacker FK, Maes RM, Jesberger JA, Nour SG, Duerk JL, Lewin JS.
MR-imaging-guided vascular procedures using carbon dioxide as a
contrast agent. AJR Am. J. Roentgenol. 2003; 181: 485–489.
2. Hargreaves BA, Gold GE, Lang PK, Conolly SM, Pauly JM,
Bergman G, et al. MR imaging of articular cartilage using driven
equilibrium. Magn. Reson. Med. 1999; 42: 695–703.
3. Petersilge C, Lewin JS, Duerk JL, Hatem SF. MR Arthrography of
the shoulder: rethinking traditional imaging procedures to meet the
technical requirements of MR imaging guidance. AJR Am. J.
Roentgenol. 1997; 169: 1453–1457.
CMR 2005: 14.06
Noninvasive hyperpolarized helium-3 imaging studies in rats under
spontaneous breathing conditions using a retrospective radial cine
imaging technique
V. Stupar,1 E. Canet-Soulas,1 S. Gaillard,1 H. Alsaid,1
N. Beckmann2 and Y. Cre´millieux1
1Laboratoire de Re´sonance Magne´tique Nucle´aire, CNRS UMR 5012,
UCBL–CPE, Universite´ Lyon-1, Lyon, France
2Discovery Technologies, Novartis Institutes for BioMedical Research,
Basel, Switzerland
Rationale and Objectives: Helium-3 ventilation imaging studies in
rats are usually performed using tracheotomy or intubation approaches
combined with assisted ventilation using respirator devices (1,2). These
approaches are not appropriate for longitudinal ventilation studies or for
precise assessment of subtle patho-physiological lung function changes.
In this work, we developed and applied a fully noninvasive imaging
protocol based on retrospective radial cine imaging under spontaneous
animal breathing conditions.
Methods: MRI experiments were performed on a 2 T magnet in Lyon.
A home-built spin-exchange apparatus was used to polarize 1.2 L of
helium-3 to around 20%. Male Sprague–Dawley rats were anesthetized
by intraperitoneal injection of sodium pentobarbital. A home-made
mask was placed on the animal head. For the imaging protocol, a plastic
bag containing 30mLof hyperpolarized helium-3 gaswas screwed on to
the mask. The projection–reconstruction sequence was triggered 2 s
later. The imaging parameters were 128 acquired samples, 200 radial
directions per image, TR¼ 10ms,TE¼ 40ms, FOV¼ 80mm, ﬂip angle
38. The total acquisition time was 20 s. Retrospective cine ventilation
image reconstructionswere based on theNMRsignal variations induced
by the animal breathing.
Results: Figure 1 shows the time evolution of the helium-3NMRsignal
intensity in the animal lungs following every RF pulse. This signal
evolution curve was obtained by plotting the magnitude of the signal in
the center of the k-space after each RF pulse. The signal amplitude
oscillation corresponds to the animal breathing cycle with maxima and
minima corresponding to the end-inspiration and end-expiration phase,
respectively. The decrease in the maximum signal intensities is due to
helium-3 T1 relaxation and RF depolarization. In most of the
acquisitions, the breathing pattern was very regular and suitable for
retrospective cine imaging. Typically, cine images were reconstructed
using a 200 ms image window. Figure 2(a) represents the ventilation
image obtained during the animal maximum lung inﬂation and
corresponding to the dashed box in Fig. 1. Figure 2(b) shows the lung
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